Literature DB >> 2530276

Structure and membrane topology of the high-affinity receptor for human IFN-gamma: requirements for binding IFN-gamma. One single 90-kilodalton IFN-gamma receptor can lead to multiple cross-linked products and isolated proteins.

M Fountoulakis1, M Kania, L Ozmen, H R Loetscher, G Garotta, A P van Loon.   

Abstract

We analyzed the high affinity receptor for IFN-gamma of Raji cells and human placenta by combining Scatchard analysis, cross-linking experiments, and receptor purification. Only one high affinity binding site was found, Kd 2.1 X 10(-10). The receptor is a 90-kDa glycoprotein. However, multiple cross-linked products of 110 kDa to about 250 kDa could be generated and proteins of 90, 70, and 50 kDa could be obtained upon purification. These proteins all contained the same 90-kDa receptor, or part of it. We suggest that extensive cross-linking and/or proteolysis may explain many of the conflicting results published thus far. The extracellular domain of the 90-kDa receptor protein was highly resistant to digestion with trypsin or proteinase K. Trypsin digestion neither affected the number of binding sites per cell, nor the Kd for IFN-gamma. A cluster of sites for different proteases was found in the intracellular domain. The 50-kDa fragment created by trypsin digestion had the same characteristics as the isolated 50-kDa receptor fragment. It contained the IFN-gamma binding site and the receptor's extracellular and amino-terminal domain. N-linked glycosylation contributed about 15 kDa to its molecular mass, of which 4 kDa were attributable to sialic acid residues. O-Linked glycosylation was not detected. The number of binding sites per cell and the Kd for IFN-gamma were not affected by the presence or absence of N-linked glycosylation. The receptor contained at least one critical disulfide bridge and the reduced receptor could be reactivated in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants.

Authors:  K Tomizawa; E Mine; A Fujii; Y Y Ohashi; S Yamagoe; Y Hashimoto; A Ishida-Okawara; M Ito; M Tanokura; T Yamamoto; Y Arimura; T Nagasawa; S Mizuno; K Suzuki
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

2.  Preparation of recombinant six-histidine-tagged human LECT2, a chemotactic protein to neutrophils, in Escherichia coli.

Authors:  M Ito; S Yamagoe; K Tomizawa; S Mizuno; M Tanokura; K Suzuki
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

3.  The human gamma interferon receptor accessory factor encoded by chromosome 21 transduces the signal for the induction of 2',5'-oligoadenylate-synthetase, resistance to virus cytopathic effect, and major histocompatibility complex class I antigens.

Authors:  U Kalina; L Ozmen; K Di Padova; R Gentz; G Garotta
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Structural analysis and localization of the carbohydrate moieties of a soluble human interferon gamma receptor produced in baculovirus-infected insect cells.

Authors:  M Manneberg; A Friedlein; H Kurth; H W Lahm; M Fountoulakis
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

5.  The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer.

Authors:  V C Gibbs; S R Williams; P W Gray; R D Schreiber; D Pennica; G Rice; D V Goeddel
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

6.  Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy.

Authors:  Qin Feng; Jingchun Yao; Ge Zhou; Wenkai Xia; Jingang Lyu; Xin Li; Tao Zhao; Guimin Zhang; Ningwei Zhao; Jie Yang
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.